A/S Novo Nordisk (manufacturing of product, filling of cartridges, and quality control of bulk products; chemical/physical testing, microbiological - sterility, and microbiological - microbial purity. Batch release)

Ukraine

All drugs from this manufacturer

  • OZEMPIC

    The drug is prescribed for the treatment of inadequately controlled type 2 diabetes mellitus as an adjunct to diet and exercise. It can be used either as monotherapy or in combination with other medicinal products.

    Dosage form: solution for injection

    Active substance Dosage
    semaglutide 1.34 mg/ml

    ATC: A10BJ06